Qatar

Reimbursed Care Access

Qatar maintains a strict, prohibition-focused regime for classical psychedelics (psilocybin, MDMA, DMT, mescaline, 2C‑X, etc.) under its national narcotics/psychotropic law (Law No. 9 of 1987) with no routine medical or reimbursed access outside authorised research or tightly controlled special-permit channels. Ketamine is available for legitimate medical indications (anesthesia, analgesia, emergency medicine) under regulatory control and supply procedures, but novel psychedelic medicines (psilocybin, MDMA, systemic DMT/5‑MeO‑DMT, ibogaine, ayahuasca) are effectively prohibited for general medical treatment and are only possible through formal research approvals or special import permits in exceptional circumstances. Official guidance emphasizes criminal penalties for unlawful possession/import and requires pre-approval from the Ministry of Public Health’s pharmacology/drug control authorities to carry or import controlled psychotropic/narcotic medicines. [https://www.unodc.org/cld/en/legislation/qat/law_no._9_of_1987_on_control_and_regulation_of_narcotic_drugs_and_dangerous_psychotropic_substances.html|Law No. 9 of 1987] [https://qatar.arablocal.com/news/traveling-to-qatar-with-medications-a-guide-to-obtaining-permission-and-carrying-medicines-safely|Qatar: Traveling with Medications Guidance].